SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN BIOLOGICAL TREATMENT OVER 65 YEARS OF AGE

被引：0
|
作者：
Crespo Golmar, A.
Moriano, C.
Gonzalez Fernandez, I.
Larco Rojas, X. E.
Lopez Robles, A.
Perez Sandoval, T.
机构：
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.5260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0622-HP
引用
收藏
页码：1267 / 1267
页数：1
相关论文
共 50 条
  • [1] MALNUTRITION IN PATIENTS WITH RHEUMATOID ARTHRITIS OVER 65 YEARS OF AGE
    Cano Garcia, L.
    Ruiz, D.
    Armenteros, P.
    Dominguez, C.
    Al Mashhadani, N.
    Mena-Vazquez, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1873 - 1874
  • [2] Pooled Safety and Efficacy of Sarilumab in Rheumatoid Arthritis Patients 65 Years of Age and Older
    Fleischmann, Roy
    Genovese, Mark C.
    van Adelsberg, Janet
    Mangan, Erin
    Iglesias-Rodriguez, Melitza
    Dukovic, Deborah
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Impact of adherence to biological agents on health care resource utilization for patients over the age of 65 years with rheumatoid arthritis
    Lathia, Urja
    Ewara, Emmanuel M.
    Nantel, Francois
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1133 - 1142
  • [4] Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65)
    Benucci, Maurizio
    Bardelli, Marco
    Cazzato, Massimiliano
    Bartoli, Francesca
    Damiani, Arianna
    Li Gobbi, Francesca
    Bandinelli, Francesca
    Panaccione, Anna
    Di Cato, Luca
    Niccoli, Laura
    Frediani, Bruno
    Mosca, Marta
    Guiducci, Serena
    Cantini, Fabrizio
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [5] Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
    Tesser, John
    Kafka, Shelly
    DeHoratius, Raphael J.
    Xu, Stephen
    Hsia, Elizabeth C.
    Turkiewicz, Anthony
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
  • [6] Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
    John Tesser
    Shelly Kafka
    Raphael J. DeHoratius
    Stephen Xu
    Elizabeth C. Hsia
    Anthony Turkiewicz
    Arthritis Research & Therapy, 21
  • [7] SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS OVER 65 YEARS OF AGE: PREVALENCE AND PREDISPOSING FACTORS.
    Garcia, L. Cano
    Dominguez, C.
    Armenteros, P.
    Vacas, J.
    Martin, J. M. Martin
    Mena-Vazquez, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1255 - 1255
  • [8] The efficacy and safety of infliximab in patients equal and over 65 years in the treatment of Japanese 5,000 patients with rheumatoid arthritis.
    Yano, Toshiro
    Togo, Masanori
    Nogami, Yoshihide
    Takeuchi, Tsutomu
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S426 - S426
  • [9] EVALUATION OF TREATMENT OF PATIENTS 65 YEARS OF AGE AND OVER FOR HYPERCHOLESTEREMIA
    ROEN, PB
    CIRCULATION, 1963, 28 (04) : 671 - &
  • [10] SAFETY AND EFFICACY OF BIOLOGICS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS IN A REAL WORLD STUDY: USE OF INTRAVENOUS GOLIMUMAB AND INFLIXIMAB IN ADULTS WITH RHEUMATOID ARTHRITIS ≥65 YEARS OF AGE
    Schechtman, J.
    Broadwell, A.
    Kafka, S.
    Black, S.
    Xu, S.
    Langholff, W.
    Schwartzman, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 527 - 528
12345